What is the appropriate aminophylline dose after Lexiscan (regadenoson)?

Aminophylline Dosing After Lexiscan (Regadenoson)

Aminophylline is administered at 50-250 mg by slow intravenous injection (50-100 mg over 30-60 seconds) to reverse persistent adverse effects from Lexiscan (regadenoson). 1

Key Dosing Information

The FDA-approved Lexiscan label provides the official dosing range for aminophylline reversal, which is 50-250 mg administered as a slow intravenous injection over 30-60 seconds 1. This is the authoritative guidance for managing regadenoson overdosage or persistent adverse effects.

When to Administer Aminophylline

Aminophylline reversal should be considered when:

• Serious cardiovascular reactions occur (myocardial ischemia, significant arrhythmias, severe hypotension) 1
• Persistent or intolerable adverse effects develop that don't resolve spontaneously
• Prolonged hyperemia needs to be terminated (particularly relevant in cardiac MRI protocols where residual hyperemia can persist 15+ minutes) 2

Important caveat: Methylxanthine use (including aminophylline) is NOT recommended in patients who experience seizures associated with regadenoson administration 1.

Clinical Context and Practical Considerations

Routine vs. Selective Use

The evidence presents two approaches:

Routine administration approach: The 2024 European guidelines note that for dipyridamole stress testing, aminophylline is "routinely given" at 70 mg over 1 minute, up to a maximum of 240 mg over 3 minutes 3. However, these guidelines specifically state that for regadenoson, "an antidote is usually not required" due to its very short half-life of only seconds 3.

Selective administration approach: The FDA label positions aminophylline as a reversal agent for persistent effects or overdosage, not routine use 1. This aligns with regadenoson's pharmacokinetics—its effects typically wear off rapidly without intervention.

Evidence for Routine Use Benefits

Despite the "not usually required" guidance, research suggests potential benefits of routine aminophylline:

• The ASSUAGE trial demonstrated that 75 mg IV aminophylline given 2 minutes post-regadenoson reduced adverse effects by 34% overall, with 50% reduction in GI symptoms and 71% reduction in headache 4
• Residual hyperemia persists: Even 15 minutes after regadenoson, residual vasodilation can affect measurements, which is completely reversed by aminophylline 2
• Symptom resolution: Complete or predominant reversal occurs in 99% of patients, with mean time to complete reversal of 162 seconds 5

Dosing Variations in Clinical Practice

Research studies have used various doses:

• 75 mg - used in the ASSUAGE trial for routine reversal 4
• 100 mg - commonly used in clinical practice studies 5, 2
• 150 mg - used in FFR measurement studies 6
• 50-100 mg over 30-60 seconds - FDA-recommended starting range 1

The most prudent approach is to start with 50-100 mg over 30-60 seconds as per FDA guidance, with the ability to titrate up to 250 mg total if needed for persistent symptoms.

Critical Safety Warnings

Administration Technique

• Administer slowly - aminophylline is potentially arrhythmogenic if given too rapidly 3
• Avoid fast bolus injections - this increases arrhythmia risk
• The slow injection over 30-60 seconds is essential for safety

Alternative Reversal Agents

During aminophylline shortages, alternatives include:

• IV theophylline: 40-75 mg (most commonly 40 mg) - demonstrated safe and effective reversal in 98% of patients 7
• IV caffeine citrate: 60 mg infused over 3-5 minutes - equivalent to aminophylline for complete reversal (87% vs 87%) 5
• Oral caffeine: Less reliable than IV options for complete reversal, though may be adequate for initial management 5

Clinical Algorithm

1. Administer regadenoson 0.4 mg IV bolus over 10 seconds 1
2. Monitor for adverse effects during and after stress imaging
3. If serious reactions occur (cardiac ischemia, severe symptoms):
   • Give aminophylline 50-100 mg IV over 30-60 seconds 1
   • Can titrate up to 250 mg total if needed
4. If routine reversal desired (to reduce adverse effects, ensure complete resolution of hyperemia):
   • Give aminophylline 75-100 mg IV 2 minutes post-regadenoson 4
5. Expect symptom resolution within 2-3 minutes of aminophylline administration 5

The decision between routine vs. selective aminophylline use should be based on your institutional protocol, patient tolerance, and whether complete reversal of hyperemia is critical for your imaging protocol (particularly important in cardiac MRI). 2